mHealth-Delivered Coaching Cuts Blood Glucose Levels in Patients With Diabetes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 3, 2023 -- A clinical pharmacist and health coach-delivered mobile health intervention can improve blood glucose levels in African American and Latinx populations, according to a study published online Sept. 29 in JAMA Network Open.
Ben S. Gerber, M.D., from University of Massachusetts Chan Medical School in Worcester, and colleagues assessed whether clinical pharmacists and health coaches using mobile health tools can improve hemoglobin A1c (HbA1c) levels. The analysis included 221 African American or Latinx patients with type 2 diabetes and elevated HbA1c (≥8 percent; aged 21 to 75 years) who received mHealth diabetes support for one year and monitored usual diabetes care for one year (order of intervention was randomly assigned).
The researchers found that in the initial 12 months, HbA1c improved by a mean of −0.79 percentage points in the intervention group versus −0.24 percentage points in the usual care group (treatment effect, −0.62). During the second year, when the intervention group switched, there was a significant change in HbA1c after the control group received the same intervention (mean change, −0.57 percentage points). During the second year, the first intervention group maintained benefit (mean change, 0.17 percentage points).
"Given their greater risk of diabetes complications compared with non-Latinx White adults, this strategy may be effective in reducing racial and ethnic disparities," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.